Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
Gidudu JF, Walco GA, Taddio A, Zempsky WT, Halperin SA, Calugar A, Gibbs NA, Hennig R, Jovancevic M, Netterlid E, O'Connor T, Oleske JM, Varricchio F, Tsai TF, Seifert H, Schuind AE; Brighton Immunization Site Pain Working Group. Gidudu JF, et al. Among authors: hennig r. Vaccine. 2012 Jun 22;30(30):4558-77. doi: 10.1016/j.vaccine.2012.03.085. Epub 2012 Apr 18. Vaccine. 2012. PMID: 22521267 No abstract available.
Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
Kohl KS, Ball L, Gidudu J, Hammer SJ, Halperin S, Heath P, Hennig R, Labadie J, Rothstein E, Schuind A, Varricchio F, Walop W; Brighton Collaboration Local Reactions Working Group for Abscess at Injection Site. Kohl KS, et al. Among authors: hennig r. Vaccine. 2007 Aug 1;25(31):5821-38. doi: 10.1016/j.vaccine.2007.04.057. Epub 2007 May 11. Vaccine. 2007. PMID: 17540485 No abstract available.
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.
Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Varricchio F, Rothstein E, Schuind A, Hennig R; Brighton Collaboration Local Reaction Working Group for Swelling at or near Injection Site. Kohl KS, et al. Among authors: hennig r. Vaccine. 2007 Aug 1;25(31):5858-74. doi: 10.1016/j.vaccine.2007.04.056. Epub 2007 May 11. Vaccine. 2007. PMID: 17548132 No abstract available.
Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
Halperin S, Kohl KS, Gidudu J, Ball L, Hammer SJ, Heath P, Hennig R, Labadie J, Rothstein E, Schuind A, Varricchio F, Walop W; Brighton Collaboration Local Reaction Working Group for Cellulitis at Injection Site. Halperin S, et al. Among authors: hennig r. Vaccine. 2007 Aug 1;25(31):5803-20. doi: 10.1016/j.vaccine.2007.04.059. Epub 2007 May 11. Vaccine. 2007. PMID: 17548135 No abstract available.
Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Hennig R, Rothstein E, Schuind A, Varricchio F; Brighton Collaboration Local Reactions Working Group for Induration at or near Injection Site. Kohl KS, et al. Among authors: hennig r. Vaccine. 2007 Aug 1;25(31):5839-57. doi: 10.1016/j.vaccine.2007.04.062. Epub 2007 May 8. Vaccine. 2007. PMID: 17553602 No abstract available.
A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
Gidudu J, Kohl KS, Halperin S, Hammer SJ, Heath PT, Hennig R, Hoet B, Rothstein E, Schuind A, Varricchio F, Walop W; Brighton Collaboration Local Reactions Working Group for a Local Reaction at or near Injection Site. Gidudu J, et al. Among authors: hennig r. Vaccine. 2008 Dec 9;26(52):6800-13. doi: 10.1016/j.vaccine.2008.10.006. Epub 2008 Oct 23. Vaccine. 2008. PMID: 18950670
Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.
Rothstein E, Kohl KS, Ball L, Halperin SA, Halsey N, Hammer SJ, Heath PT, Hennig R, Kleppinger C, Labadie J, Varricchio F, Vermeer P, Walop W; Brighton Collaboration Local Reaction Working Group. Rothstein E, et al. Among authors: hennig r. Vaccine. 2004 Jan 26;22(5-6):575-85. doi: 10.1016/j.vaccine.2003.09.005. Vaccine. 2004. PMID: 14741147 Review. No abstract available.
Template protocol for clinical trials investigating vaccines--focus on safety elements.
Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker KB, Wilson P, Wong V, Zaman K, Heininger U; Brighton Collaboration Clinical Trial Protocol Working Group. Bonhoeffer J, et al. Vaccine. 2013 Nov 12;31(47):5602-20. doi: 10.1016/j.vaccine.2013.02.041. Epub 2013 Mar 13. Vaccine. 2013. PMID: 23499603 Free PMC article.
Safety of MF59 adjuvant.
Schultze V, D'Agosto V, Wack A, Novicki D, Zorn J, Hennig R. Schultze V, et al. Among authors: hennig r. Vaccine. 2008 Jun 19;26(26):3209-22. doi: 10.1016/j.vaccine.2008.03.093. Epub 2008 Apr 21. Vaccine. 2008. PMID: 18462843 Review.
228 results